SCHEMBL3201539

SCHEMBL3201539

Nc1c(O)c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 5/20 0.54
NSD2 O96028 2/20 0.54
DUSP3 P51452 1/20 0.54
PTPN5 P54829 1/20 0.54
PTPN11 Q06124 1/20 0.54
ALDH1A1 P00352 5/20 0.53
HSD17B10 Q99714 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2C19 P33261 1/20 0.53
CYP1A2 P05177 3/20 0.51
HIF1A Q16665 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
MEN1 O00255 1/20 0.51
THRB P10828 1/20 0.51
KMT2A Q03164 1/20 0.51
NT5E P21589 3/20 0.50
ENPP2 Q13822 3/20 0.50
SUMO2 P61956 1/20 0.45
SUMO1 P63165 1/20 0.45
SENP7 Q9BQF6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16817741 1.00 CASP6 (0.54) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL29475260 1.00 CASP6 (0.54) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL8100909 0.98 CASP6 (0.53) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL16817740 0.98 CASP6 (0.53) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL8100906 0.89 CASP6 (0.50) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL517711 0.87 CASP6 (0.54) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL19667862 0.87 ALDH1A1 (0.56) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL3203561 0.85 ALDH1A1 (0.54) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL4280353 0.85 ALDH1A1 (0.54) CASP6NSD2DUSP3PTPN5PTPN11
SCHEMBL27999026 0.84 ALDH1A1 (0.53) CASP6NSD2DUSP3PTPN5PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333472-A1 Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto GEORGE MASON RES FOUNDATION INC (US) 2025-10-30 US disclosed
US-12331096-B2 Binding domain mapping and compounds, compositions, complexes, methods, and kits related thereto George Mason Research Foundation, Inc. (US) 2025-06-17 US disclosed
WO-2020142700-A1 BINDING DOMAIN MAPPING AND COMPOUNDS, COMPOSITIONS, COMPLEXES, METHODS, AND KITS RELATED THERETO George Mason Research Foundation, Inc. (US) 2020-07-09 WO disclosed
EP-2123724-B1 AQUEOUS INK COMPOSITION FOR BALLPOINT PEN PILOT INK CO LTD (JP) 2018-05-23 EP disclosed
EP-2886542-B1 Marker dyes for UV and short-wave excitation with high Stokes shift on the basis of benzoxazoles DYOMICS GMBH (DE) 2018-04-18 EP disclosed
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
EP-2886542-A1 Marker dyes for UV and short-wave excitation with high Stokes shift on the basis of benzoxazoles Dyomics GmbH (DE) 2015-06-24 EP disclosed
EP-2018847-B1 Hair composition comprising at least one direct disulfide dye and at least one alkali hydroxide agent and method of simultaneous styling and dyeing. ORÉAL L (FR) 2014-09-17 EP disclosed
US-8764333-B2 Water based ink compositions for ballpoint pen THE PILOT INK CO., LTD. (JP) 2014-07-01 US disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
EP-0985538-B1 Ink jet printing process XEROX CORP (US) 2005-12-14 EP disclosed
US-6312121-B1 Ink jet printing process XEROX CORPORATION 2001-11-06 US disclosed
EP-0985538-A2 Ink jet printing process XEROX CORPORATION (US) 2000-03-15 EP disclosed
US-5478927-A Bisazo compounds and use thereof as fiber reactive dyes SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-12-26 US disclosed
US-4845203-A FOR CELLULOSE FIBERS CIBA-GEIGY CORPORATION (US) 1989-07-04 US disclosed
US-4808706-A WET- AND LIGHFAST; SOLUBLE CIBA-GEIGY CORPORATION (US) 1989-02-28 US disclosed
US-4740592-A Water-soluble azo compounds containing fiber-reactive groups and having a sulfo-naphthal coupling component with a triazinylamino substituent suitable as dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1988-04-26 US disclosed
EP-0083052-A1 Reactive disazo dyes, process for their preparation and their use in dyeing and printing hydroxyl or nitrogen containing fibrous materials BAYER AG (DE) 1983-07-06 EP disclosed
US-4163675-A CONTAINING NAPHTHALENE DERIVATIVES PILOT INK CO., LTD. (JP) 1979-08-07 US disclosed
US-4113632-A ALIPHATIC SUBSTITUTED SUCCINIMIDO ARYL HYDROXY SULFONATE OR ITS SUCCINAMIC ACID DERIVATIVE MOBIL OIL CORPORATION (US) 1978-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333472-A1 Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto SNRPE, SSBP1, RPA1 CASP6 3035/4885NSD2 4541/4885DUSP3 3182/4885
US-12331096-B2 Binding domain mapping and compounds, compositions, complexes, methods, and kits related thereto SNRPE, SSBP1, RPA1 CASP6 3035/4885NSD2 4541/4885DUSP3 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.